Y Funae
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
- Inflammatory mediators and NSAID effects 2
- Oncology 4
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Susumu Imaoka (6 shared papers)Tetsuya Kamataki (4 shared papers)Masatoshi Nakajima (2 shared papers)Tsuyoshi Yokoi (2 shared papers)Noriaki Shimada (1 shared paper)Kazunori Nagashima (1 shared paper)Takahiko Yamamoto (1 shared paper)Katsuhiro Inoue (1 shared paper)
- Journals
- Biochimica et Biophysica Acta (BBA) - General Subjects (2 papers)Xenobiotica (1 paper)Cancer Letters (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Carcinogenesis (1 paper)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Y Funae
11 papers receiving 614 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 330
- Biochemistry 64
- Oncology 143
- Cancer Research 62
- Physiology 108
Countries citing papers authored by Y Funae
This map shows the geographic impact of Y Funae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Funae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Funae more than expected).
Fields of papers citing papers by Y Funae
This network shows the impact of papers produced by Y Funae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Funae. The network helps show where Y Funae may publish in the future.
Co-authors
The 25 scholars most cited alongside Y Funae, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 249 | |
| 2 | 1985 | 151 | |
| 3 | 2003 | 71 | |
| 4 | Nicotine metabolism in liver microsomes from rats with acute hepatitis or cirrhosis. | 1998 | 35 |
| 5 | Effect of phenobarbital on the pharmacokinetics of lidocaine, monoethylglycinexylidide and 3-hydroxylidocaine in the rat: correlation with P450 isoform levels. | 1997 | 27 |
| 6 | 1993 | 22 | |
| 7 | Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine. | 1997 | 21 |
| 8 | Form-specific degradation of cytochrome P-450 by lipid peroxidation in rat liver microsomes. | 1989 | 20 |
| 9 | 2005 | 17 | |
| 10 | 1996 | 14 | |
| 11 | Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans. | 1997 | 10 |
About Y Funae
Y Funae is a scholar working on Pharmacology, Oncology, Spectroscopy, Pharmacology and Transplantation, having authored 11 papers that have together received 637 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (4 papers), Analytical Chemistry and Chromatography (3 papers), Synthesis and Biological Evaluation (2 papers), Inflammatory mediators and NSAID effects (2 papers), Nicotinic Acetylcholine Receptors Study (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Pharmacology (330 citations), Biochemistry (64 citations), Oncology (143 citations), Cancer Research (62 citations) and Physiology (108 citations). Y Funae has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Susumu Imaoka, Tetsuya Kamataki, Masatoshi Nakajima, Tsuyoshi Yokoi, Noriaki Shimada, Kazunori Nagashima, Takahiko Yamamoto, Katsuhiro Inoue, Y Kuroiwa and Shoji Fukushima. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - General Subjects, Xenobiotica, Cancer Letters, Journal of Pharmacology and Experimental Therapeutics and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.